Climb Bio
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20 William St Ste 145, Wellesley Hills, ...Phone Number
(866) 857-2596Website
www.climbbio.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Climb Bio
Climb Bio is a clinical-stage biotechnology company developing monoclonal antibody therapies for immune-mediated diseases. Its pipeline targets B-cell and immune pathways to address conditions with significant unmet medical needExplore more
Climb Bio Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Climb Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Climb Bio recently announced quarterly report
Funding: Get notified immidiatlly once Climb Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Climb Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Climb Bio had a recent Job posting/layoffs
Climb Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Climb Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Climb Bio is spiking on competitors!
Product Launch: Get notified when Climb Bio launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Climb Bio as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Climb Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Climb Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Climb Bio.
Climb Bio financials insights
Gather financial insights about Climb Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$110.1M
Climb Bio Tech Stack
A closer look at the technologies used by Climb Bio
See more technologies
Most Recent Scoops
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Climb Bio News & Media
Climb Bio to Present at Upcoming Investor Conferences
WELLESLEY HILLS, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below.Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
CLYM116 Phase 1 data in healthy volunteers to be presented at R&D Spotlight Event on September 3, 2026Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026
Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopeniaClimb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development
Company to share additional CLYM116 clinical data and plans for further development at R&D Spotlight in late summer
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Climb Bio
Sign Up For FreeTo access detailed company insights
Climb Bio is a clinical-stage biotechnology company developing monoclonal antibody therapies for immune-mediated diseases. Its pipeline targets B-cell and immune pathways to address conditions with significant unmet medical need... Read More
